Amerisource Meclizine Recall - Failed Tablet Specifications
Summary
Amerisource Health Services LLC, distributed by American Health Packaging, initiated a Class II recall of Meclizine Hydrochloride Tablets, USP 12.5 mg nationwide. The recall (D-0418-2026) was initiated due to failed tablet specifications affecting products with NDC codes 60687-775-65 and 60687-775-11. The recall is ongoing with no specific return deadline provided.
What changed
Amerisource Health Services LLC, through American Health Packaging (Columbus, OH), initiated a Class II drug recall for Meclizine Hydrochloride Tablets, USP 12.5 mg. The recall affects two product configurations: 50-tablet bottles (NDC 60687-775-65) and individual dose units (NDC 60687-775-11). The reason for recall is failed tablet specifications. The recall has no specified return deadline and remains ongoing as of April 1, 2026.
Healthcare providers and pharmacies should immediately check inventory for the affected NDC codes and quarantine any remaining stock. Patients who have received this medication should be notified and advised to return the product to their pharmacy. Manufacturers and distributors in the supply chain should verify their records to identify potentially affected lots and coordinate with Amerisource for return procedures.
What to do next
- Verify inventory for NDC 60687-775-65 and 60687-775-11
- Quarantine and segregate any affected product found in stock
- Notify patients who may have received the recalled Meclizine 12.5mg tablets
Archived snapshot
Apr 7, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Amerisource Health Services LLC
Drug Recalls (Class II)
← All Drug Recalls (Class II) Class II D-0418-2026 · 20260401 · Ongoing
Product
Meclizine Hydrochloride Tablets, USP 12.5 mg, (a) 50 Tablets 5 x 10 (b) 12.5 mg Individual Dose ( NDC 60687-775-11), Rx Only, Distributed by: American Health Packaging, Columbu...
Reason for Recall
Failed tablet specifications.
Distribution
U.S. Nationwide
Source: openFDA Enforcement API
Named provisions
Related changes
Get daily alerts for FDA: Drug Recalls Class II
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from FDA.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when FDA: Drug Recalls Class II publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.